Private equity firm Blackstone agreed to acquire orthopedic and anti-rheumatism pharmaceutical company Ayumi Pharmaceutical Corp.
What you should know:
1. If completed, the transaction will be Blackstone's first in the Japanese market.
2. The transaction could close in the second quarter of 2019.
3. Ayumi's flagship product Calonal is a leading acetaminophen drug used to treat chronic pain.
4. Ayumi also has a comprehensive synthetic and biosimilar product portfolio.